BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23635006)

  • 1. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
    Salmans ML; Zhao F; Andersen B
    Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.
    Verma S; Salmans ML; Geyfman M; Wang H; Yu Z; Lu Z; Zhao F; Lipkin SM; Andersen B
    Dev Biol; 2012 Sep; 369(2):249-60. PubMed ID: 22819674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer.
    Li Z; Zhu Q; Chen H; Hu L; Negi H; Zheng Y; Ahmed Y; Wu Z; Li D
    Cancer Lett; 2016 Jul; 377(1):32-43. PubMed ID: 27063095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer.
    Wright TM; Wardell SE; Jasper JS; Stice JP; Safi R; Nelson ER; McDonnell DP
    Mol Cancer Res; 2014 Dec; 12(12):1829-39. PubMed ID: 25100862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.
    Hrstka R; Nenutil R; Fourtouna A; Maslon MM; Naughton C; Langdon S; Murray E; Larionov A; Petrakova K; Muller P; Dixon MJ; Hupp TR; Vojtesek B
    Oncogene; 2010 Aug; 29(34):4838-47. PubMed ID: 20531310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
    Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
    Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis.
    Higa A; Mulot A; Delom F; Bouchecareilh M; Nguyên DT; Boismenu D; Wise MJ; Chevet E
    J Biol Chem; 2011 Dec; 286(52):44855-68. PubMed ID: 22025610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
    Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
    J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.
    Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP
    Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells.
    Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH
    BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
    Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
    Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients.
    Zamzam Y; Abdelmonem Zamzam Y; Aboalsoud M; Harras H
    Int J Surg Oncol; 2021; 2021():9947540. PubMed ID: 34567804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance].
    Wu ZS; Wu Q; Ding XD; Wang HQ; Shen YX; Fang SY
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):109-13. PubMed ID: 18681322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells.
    Bouchalova P; Sommerova L; Potesil D; Martisova A; Lapcik P; Koci V; Scherl A; Vonka P; Planas-Iglesias J; Chevet E; Bouchal P; Hrstka R
    Mol Cell Proteomics; 2022 Feb; 21(2):100188. PubMed ID: 34929376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological stress induces the metastasis marker AGR2 in breast cancer cells.
    Zweitzig DR; Smirnov DA; Connelly MC; Terstappen LW; O'Hara SM; Moran E
    Mol Cell Biochem; 2007 Dec; 306(1-2):255-60. PubMed ID: 17694278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape.
    Maarouf A; Boissard A; Henry C; Leman G; Coqueret O; Guette C; Lelièvre E
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
    Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
    Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.
    Hrstka R; Brychtova V; Fabian P; Vojtesek B; Svoboda M
    Dis Markers; 2013; 35(4):207-12. PubMed ID: 24167368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.
    Zhou M; Gan XL; Ren YX; Chen QX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
    BMC Cancer; 2023 Aug; 23(1):743. PubMed ID: 37568077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.